Thought Leadership - Spherix Global Insights

Invest in intelligence that delivers

Spherix Thought Leadership

From conference presentations to white papers and other publicly shared research, access a comprehensive collection to stay informed and drive impactful decisions.

Hematology

Evolving Treatment Priorities in Hemophilia: Physician and Patient Perspectives on Convenience, Quality of Life, and the Emerging Role of Rebalancing Agents Across the US and EU5

Hematology

Divergent Pathways: Comparative Logistical and Perceptual Barriers to Gene Therapy Adoption in Hemophilia Versus Hemoglobinopathies in the United States

Rheumatology

Alignment Between 2025 EULAR Lupus Nephritis Guidelines and Real-World Practice in Europe: Current Use of Early Quadruple Therapy and Anticipated Impact of Obinutuzumab Approval

Nephrology

From referral to escalation: Misalignment between disease severity and treatment action in real-world IgAN

Nephrology

Identifying rapid progressors in IgAN: Reliance on traditional markers amid persistent risk stratification gaps

Nephrology

From target to reality: Proteinuria targets align with KDIGO guidance, but progression persists in real-world IgAN

Oncology

Operational and clinical drivers of subcutaneous PD-1/PD-L1 inhibitor adoption: A mixed-methods analysis of U.S. oncology practice patterns.

Nephrology

Who Reaches Home Dialysis—and Who Doesn’t: Disparities in Access and Maintenance Across Dialysis Modalities

Nephrology

Preferred but Restricted: Impact of the End Stage Renal Disease Bundle on Dialysis Treatment

Dermatology

Shifting Role of Oral Therapies in Psoriasis: Unmet Needs and Perspectives on Current and Emerging Therapies, and Evolving Treatment Sequencing Among Dermatologists

Dermatology

Evolving Real-World Treatment Patterns and Unmet Needs in Atopic Dermatitis in the United States: Insights from a 2025 Patient Chart Audit and Market Landscaping Study

Ophthalmology

How Next-Gen Therapies Will Reshape nAMD and DME Management

Gastroenterology

Rezdiffra and Wegovy are Just the Beginning: Vast Unmet Needs and Opportunities Remain in the Fight Against MASH

Hematology

Gene Therapy in Hematology: What Explains the Uptake Gap?

Rheumatology

Retrospective Chart Audit Reveals Gaps in Steroid Tapering and Use of ACR Guideline-Recommended Regimens in LN

Gastroenterology

PCPs and Endocrinologists Foresee Increased Screening and Greater Responsibility in MASH Management in the Near Future

Nephrology

A New Era in Kidney Disease Treatment? Rapid Adoption of SGLT2is and GLP-1s Signals Shifting Paradigms

Nephrology

Same Disease, Different Stories: Contrasting Patient and Physician Perspectives in IgA Nephropathy

Rheumatology

Navigating the Evolving SLE/Lupus Nephritis Landscape: Keys to Successful Product Launches

Hematology

Advancing Hemophilia Care: Insights from U.S. Hematologists on Novel Therapies and Clinical Practice Trends

Hematology

Advancing Hemophilia Care: Insights from U.S. Hematologists on Novel Therapies and Clinical Practice Trends

Hematology

New treatment dynamics in PNH – a chart review of 211 US PNH patients and how physicians are adapting to new treatment options

Cross Specialty

Discussion on the Inflation Reduction Act During the Healthcare Businesswomen's Association Virtual Event

Dermatology

Earlier Diagnosis and Treatment: The Key to Better Outcomes in Hidradenitis Suppurativa

Dermatology

Understand the remaining unmet need in plaque psoriasis and to uncover early perceptions of the oral small molecules in development for plaque psoriasis.

Nephrology

A Complement and B-Cell Modifying Pipeline to Address Unmet Needs in IgA Nephropathy (IgAN)

Rheumatology

Chart Audit of Over 1,000 SLE Patients Reveals Biologic Treatment Choice Driven by Disease Manifestations

Dermatology

Uptake of Secukinumab in Hidradenitis Suppurativa

CNS

A KOL Perspective: Exclusive Interview with Dr. Naismith

Rheumatology

Not Yet on Track: Retrospective Chart Analysis Reveals Physician’s Treatment Approaches in SLE Fall Short of New EULAR Guidance

Nephrology

Evolution of Treatment Paradigms in Diabetic Kidney Disease

CNS

Characterization of Early Adopters of SC FcRn Blockers for gMG

Nephrology

The Untapped Potential of the ADPKD Treatment Landscape

Rheumatology

Amplifying the Lupus Patient Voice: Insights into the Diagnostic Journey and Informational Needs

Nephrology

The Meteoric Rise of SGLT2 Inhibitors in Glomerular Diseases

Dermatology

Acceptable Clinical Trial Differences vs Placebo in Plaque Psoriasis

Nephrology

A Comparative View of IgA Nephropathy Care Across Four Global Regions

Nephrology

Genetic Testing in Patients with Focal Segmental Glomerulosclerosis

Rheumatology

Specialists' Comfort with Cutaneous Lupus Erythematosus Reveals Potential Gaps and a Need for Co- Management Strategies

Nephrology

A Comparative View of Early Career and Established Nephrologist Perspectives

CNS

The Uptake of Relyvrio™ (sodium phenylbutyrate and taurursodiol) in ALS among General Neurologists Compared to Neuromuscular Specialists and to ALS Center Affiliated Neurologists

Nephrology

Uncovering the Potential of HIF-PH Inhibitors to Treat Renal Anemia

Dermatology

Real-World Differences and Unmet Needs in Chronic Spontaneous Urticaria (CSU)

Nephrology

Shifts in SGLT2 Inhibitor Initiation in CKD Non-Dialysis Patients

Nephrology

A New Era for FSGS Treatment

Media

Novo’s success with oral Wegovy has been fueled by ‘familiarity’: Spherix

June 18, 2026

CTD-ILD Enters New Treatment Era, but Physicians Still See Significant Unmet Need

June 17, 2026

Wayrilz (rilzabrutinib, Sanofi) Positioned to Define Third-Line Treatment in Warm Autoimmune Hemolytic Anemia (w-AIHA) as IMAAVY (niopcalimab, Jonhson & Johnson) Follows Closely with Positive Data Announcement at EHA 2026

June 12, 2026

Brepocitinib Interest Gains Momentum in Idiopathic Inflammatory Myopathies as Rheumatologists Signal Readiness for Targeted, Steroid-Sparing Therapies

May 28, 2026

Talk to an expert

Sybil Mead
Vice President of Market Access

Andy Stankus

Franchise Head, Dermatology

Jim Hickey
Franchise Head, Gastroenterology

Lynn Price
Franchise Head, Rheumatology

Kari McCarthy
Franchise Head, Nephrology

Sarah Soucy
Franchise Head, CNS

Sarah Soucy
Franchise Head, Ophthalmology

Sarah Hendry
Franchise Head, Hematology

Sarah Hendry
Franchise Head, Oncology